The scientific commons in the marketplace: The industrialization of biomedical materials at the New England Enzyme Center, 1963-1980

History and Technology

Volumn 25, Issue 1, 2009, Pages 69-87

  Yi, Doogab ^a  

^a NONE

Author keywords

Biomedical materials; Biotechnology; Genzyme; National Institutes of Health; New England Enzyme Center; Private markets; Scientific commons

Indexed keywords

EID: 60549112758     PISSN: 07341512     EISSN: 14772620     Source Type: Journal    
DOI: 10.1080/07341510802618182     Document Type: Article

References (72)

1. Abir-Am, Pnina G. (1982) The Discourse of Physical Power and Biological Knowledge in the 1930s: A Reappraisal of the Rockefeller Foundation's "Policy" in Molecular Biology. Social Studies of Science, 12, pp. 341-382.
2. Anderson, Warwick (2000) The Possession of Kuru: Medical Science and Biocolonial Exchange. Comparative Studies in Society and History, 42, pp. 713-744.
3. Appel, Toby A. (2000) Shaping Biology: The National Science Foundation and American Biological Research, 1945-1975, Johns Hopkins University Press, Baltimore
4. Arrow, Kenneth J. (1959) 'Economic Welfare and the Allocation of Resources for Invention.' The Rand Corporation, Economics Division. P-1856-RC, pp. 1-23.
5. Berman, Elizabeth P. (2007) Creating the Market University: Science, the State, and the Economy, 1965-1985. PhD diss. University of California, Berkeley
6. Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer Jr., E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T. and Tasumi, M. (1977) The Protein Data Bank: A Computer-Based Archival File for Macromolecular Structures. Journal of Molecular Biology, 112, pp. 535-542.
7. Beutler, E. (1991) Gaucher Disease. New England Journal of Medicine, 325, pp. 1354-1360.
8. Brady, Roscoe O. (2003) Enzyme Replacement Therapy: Concept, Chaos, and Culmination. Philosophical Transactions of the Royal Society of London, Series B, 358, pp. 915-919.
9. Bush, Vannevar (1945) Science, the Endless Frontier: A Report to the President on a Program for Postwar Scientific Research, United States Government Printing Office, Washington, D.C.
10. Chandler, Alfred D. (2005) Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries, Harvard University Press, Cambridge
11. Cooke-Deegan, Robert (2007) The Science Commons in Health Research: Structure, Function, and Value. The Journal of Technology Transfer, 32, pp. 133-156.
12. Creager, A. N. H. (1996) Wendell Stanley's Dream of a Free-standing Biochemistry Department at the University of California, Berkeley. Journal of the History of Biology, 29, pp. 331-360.
13. Creager, A. N. H. (1999) "What Blood Told Dr Cohn": World War II, Plasma Fractionation, and the Growth of Human Blood Research. Studies in History and Philosophy of Biological and Biomedical Sciences, 30, pp. 377-405.
14. Creager, A. N. H. (2002) Tracing the Politics of Changing Postwar Research Practices: The Export of "American" Radioisotopes to European Biologists. Studies in History and Philosophy of Biological and Biomedical Sciences, 33, pp. 367-388.
15. Creager, A. N. H. (2004) The Industrialization of Radioisotopes by the US Atomic Energy Commission. The Science-Industry Nexus: History, Policy, Implications, pp. 143-167. Science History Publications, Sagamore Beach
16. Dale, G. L. and Beutler, E. (1976) Enzyme Replacement Therapy in Gaucher's Disease: A Rapid, High-Yield Method for Purification of Glucocerebrosidase. Proceedings of the National Academy of Sciences, 73, pp. 4672-4674.
17. De Chadarevian, Soraya (1997) Sequences, Conformation, Information: Biochemists and Molecular Biologists in the 1950s. Journal of the History of Biology, 29, pp. 361-386.
18. De Chadarevian, Soraya (2002) Designs for Life: Molecular Biology after World War II, Cambridge University Press, Cambridge
19. Edgerton, David (2004) "The Linear Model" Did not Exist: Reflections on the History and Historiography of Science and Research in Industry in the Twentieth Century. The Science-Industry Nexus: History, Policy, Implications, pp. 31-58. Science History Publications, Sagamore Beach
20. Eisenberg, Rebecca S. (1996) Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research. Virginia Law Review, 82, p. 1663.
21. Englander, Ernest J. (1991) The Political Economy of Biotechnology: Innovation and Politics in an Emerging Industry. Business and Economic History, 20, pp. 136-141.
22. Etzkowitz, Henry (2003) MIT and the Rise of Entrepreneurial Science, Routledge, New York
23. Fones-Wolf, Elizabeth A. (1995) Selling Free Enterprise: The Business Assault on Labor and Liberalism, 1945-60, University of Illinois Press, Urbana
24. Furbish,. F. Scott, Blair, Henry, Shiloach, Joseph, Pentchev, Peter G. and Brady, Roscoe O. (1977) Enzyme Replacement Therapy in Gaucher's Disease: Large-scale Purification of Glucocerebrosidase Suitable for Human Administration. Proceedings of the National Academy of Sciences, 74, pp. 3560-3563.
25. Garber, Alan M., Clarke, Ann E., Goldman, Dana P. and Gluck, Michael E. Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease.
26. Gaudilliere, Jean-Paul (1998) The Molecularization of Cancer Etiology in the Postwar United States: Instruments, Politics and Management. Molecularizing Biology and Medicine: New Practices and Alliances, 1910-1970s, pp. 139-170. Harwood Academic Press, Amsterdam
27. (1998) The Invisible Industrialist: Manufactures and the Production of Scientific Knowledge, St. Martin's Press, New York
28. Geiger, Roger L. (1993) Research and Relevant Knowledge: American Research Universities since World War II, Oxford University Press, New York
29. Geiger, Roger L. (2004) Knowledge and Money: Research Universities and the Paradox of the Marketplace, Stanford University Press, Stanford, CA
30. Grunberg-Manago, Marianne, Ortiz, Priscilla J. and Ochoa, Severo (1955) Enzymatic Synthesis of Nucleic Acidlike Polynucleotides. Science, 122, pp. 907-910.
31. Hall, Stephen S. (1987) Invisible Frontiers: The Race to Synthesize a Human Gene, Atlantic Monthly Press, New York
32. Heller, Michael A. (1998) The Tragedy of the Anticommons: Property in the Transition from Marx to Market. Harvard Law Review, 111, pp. 621-688.
33. Heller, Michael A. and Eisenberg, Rebecca S. (1998) Can Patents Deter Innovation? The Anticommons in Biomedical Research. Science, 280, pp. 698-701.
34. Helvoort, Ton van (2002) Institutionalizing Biochemistry: The Enzyme Institute at the University of Wisconsin. Journal of the History of Medicine and Allied Sciences, 57, pp. 449-479.
35. Hollinger, David A. (1990) Free Enterprise and Free Inquiry: The Emergence of Laissez-faire Communitarianism in the Ideology of Science in the US. New Literary History, 21, pp. 897-919.
36. Holmes, Frederic L. (1992) Between Biology and Medicine: The Formation of Intermediary Metabolism, University of California Press, Berkeley
37. Hughes, Sally S. (2001) Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974-1980. Isis, 92, pp. 541-575.
38. Johns, Adrian (2006) Intellectual Property and the Nature of Science. Cultural Studies, 20:23, pp. 145-164.
39. Kay, Lily E. (1986) W. M. Stanley's Crystallization of the Tobacco Mosaic Virus, 1930-1940. Isis, 77, pp. 450-472.
40. Kay, Lily E. (2000) Who Wrote the Book of Life? A History of the Genetic Code, Stanford University Press, Stanford
41. Kenney, Martin (1986) Biotechnology: The University-Industrial Complex, Yale University Press, New Haven
42. Kevles, Daniel J. (1994) Ananda Chakrabarty Wins a Patent: Biotechnology, Law and Society, 1972-1980. Historical Studies in the Physical and Biological Sciences, 25, pp. 111-135.
43. Kevles, Daniel J. (2001) Principles, Property Rights, and Profits: Historical Reflections on University/Industry Tensions. Accountability in Research, 8, pp. 12-26.
44. Kleinman, Daniel L. and Vallas, Steven (2001) Science, Capitalism, and the Rise of the "Knowledge Worker": The Changing Structure of Knowledge Production in the United States. Theory and Society, 30, pp. 451-492.
45. Kohler, Robert E. (1994) Lords of the Fly: Drosophila Genetics and the Experimental Life, University of Chicago Press, Chicago
46. Landecker, Hannah (2003) 'Sending Cells Around: How to Exchange Biological Matter.'. Paper presented in The Moment of Conversion: Exchange Networks in Modern Biomedical Science, Department of Anthropology, History, and Social Medicine University of California, San Francisco
47. Lazonick, William and Tulum, Oner (2008) 'US Biopharmaceutial Finance and the Sustainability of the Biotech Boom.'. Paper presented at the 2008 Conference on Entrepreneurship and Innovations: Organizations, Institutions, Systems, and Regions, Copenhagen
48. Lessig, Lawrence (1999) Code and Other Laws of Cyberspace, Basic Books, New York
49. Lowy, Ilana (1997) Between Bench and Bedside: Science, Healing, and Interleukin-2 in a Cancer Ward, Harvard University Press, Cambridge
50. Mackenzie, Michael, Cambrosio, Alberto and Keating, Peter (1988) The Commercial Application of a Scientific Discovery: The Case of the Hybridoma Technique. Research Policy, 17, pp. 155-170.
51. Merton, Robert K. (1942) The Sociology of Science: Theoretical and Empirical Investigations, University of Chicago Press, Chicago
52. (2004) Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act in the United States, Stanford University Press, Stanford
53. Mowery, David C. and Sampat, Bhaven N. (2001) University Patents and Patent Policy Debates in the USA, 1925-1980. Industrial and Corporate Change, 10, pp. 781-814.
54. Nash, George H. (2006) Conservative Intellectual Movement in America since 1945, Basic Books, New York
55. Nelson, Richard (2004) The Market Economy, and the Scientific Commons. Research Policy, 33, pp. 455-471.
56. O'Brien, Keith (2007) Cracking the Biotech Code. The Scientist, pp. 69-71.
57. Owens, Larry (1991) Patents, the "Frontiers" of American Invention, and the Monopoly Committee of 1939: Anatomy of a Discourse. Technology and Culture, 32, pp. 1076-1093.
58. Pentchev, Peter G. and Brady, Roscoe O. Isolation of Glucocerebrosidase from Human Placental Tissue.
59. Pentchev, Peter G., Brady, Roscoe O., Hibbert, Sue R., Gal, Andrew E. and Shapiro, David (1973) Isolation and Characterization of Glucocerebrosidase from Human Placental Tissue. Journal of Biological Chemistry, 248, pp. 5256-5261.
60. Pisano, Gary P. (2006) Science Business: The Promise, the Reality, and the Future of Biotech, Harvard Business School Press, Cambridge
61. Rabinow, Paul (1996) Making PCR: A Story of Biotechnology, University of Chicago Press, Chicago
62. Rader, Karen A. (2004) Making Mice: Standardizing Animals for American Biomedical Research, 1900-1955, Princeton University Press, Princeton
63. Rai, Arti K. (1999) Regulating Scientific Research: Intellectual Property Rights and the Norms of Science. Northwestern University Law Review, 94, pp. 77-152.
64. Rasmussen, Nicolas (1997) Picture Control: The Electron Microscope and the Transformation of Biology in America, 1940-1960, Stanford University Press, Stanford
65. Rheinberger, Hans-Jorg (1997) Toward a History of Epistemic Things: Synthesizing Proteins in the Test Tube, Stanford University Press, Stanford, CA
66. Strasser, Bruno J. (2006) Collecting and Experimenting: The Moral Economies of Biological Databases, 1960s-1980s. Preprints of the Max-Planck Institute for the History of Science, 310, pp. 105-123.
67. Thackray, Arnold (1998) Private Science: Biotechnology and the Rise of the Molecular Sciences, University of Pennsylvania Press, Philadelphia
68. Tobbell, Dominique A. (2008) "Who's Winning the Human Race?" Cold War as Pharmaceutical Political Strategy. Unpublished Manuscript
69. Vettel, Eric J. (2006) Biotech: The Countercultural Origins of an Industry, University of Pennsylvania Press, Philadelphia
70. Westwick, Peter J. (2003) The National Labs: Science in an American System, 1947-1974, Harvard University Press, Cambridge, MA
71. Wright, Susan (1986) Recombinant DNA Technology and its Social Transformation, 1972-1982. Osiris, 2, pp. 303-360.
72. Yi, Doogab (2008) Cancer, Viruses, and Mass Migration: Paul Berg's Venture into Eukaryotic Biology and the Advent of Recombinant DNA Technology and Research, 1967-1980. Journal of the History of Biology, 41, pp. 589-636.